Smoking Cessation and Nicotine De-Addiction Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2032
18.9%
CAGR (2025-2032)
21.79 USD Bn.
Market Size
317
Report Pages
152
Market Tables
Overview
The Smoking Cessation and Nicotine De-Addiction Market size was valued at USD 21.79 Billion in 2024 and the total Smoking Cessation and Nicotine De-Addiction revenue is expected to grow at a CAGR of 18.90% from 2025 to 2032, reaching nearly USD 87.03 Billion.
Smoking Cessation and Nicotine De-Addiction Market Dynamics:
Growing awareness among cigarette smokers about the health disadvantages of smoking such as lung cancer, cardiac diseases, and other respiratory problems, has forced the global market. Initiatives assisted by governments to make awareness concerning the harmful effects of smoking with the help of information brochures, warning labels, discouraging imagery on cigarette packages, television ads, and newspapers are also driving the growth of the global smoking cessation and nicotine de-addiction market.
There are also some non-government organizations functioning to help and educate people to stop smoking and are frequently involved in reducing the number of customers. This will allow the smoking cessation and nicotine de-addiction market to increase in the future. Moreover, the availability of a large range of nicotine replacement therapy (NRT) products through retail & online selling platforms is also fueling the growth . Nevertheless, less consciousness about smoking cessation products in emerging economies is hindering the growth of the global smoking cessation and nicotine de-addiction market.
To know about the Research Methodology :- Request Free Sample Report
Smoking Cessation and Nicotine De-Addiction Market Regional Insights:
According to the product type, the e-cigarettes segment is expected to grow at the highest CAGR of xx% throughout the forecasted period and this is due to e-cigarettes' capacity to replicate the same sensation as smoking a conventional cigarette while reducing the health risks related with the latter. The increasing acceptance of e-cigarettes is on account of the obtainability of a variation of flavors and nicotine concentrations.
Region-wise, the North Americas is leading the smoking cessation and nicotine de-addiction market with its innovations in smoking cessation products, and account for about 45% of the global smoking cessation and nicotine de-addiction market. Asia-Pacific is expected to have the largest growth rate throughout the forecast period thanks to high tobacco consumption in this region, in addition to rising disposable income.
The objective of the report is to present comprehensive analysis of Global Smoking Cessation and Nicotine De-Addiction Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Market dynamics, structure by analyzing the market segments, and project the Global Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Smoking Cessation and Nicotine De-Addiction Market Scope: Inquire before buying
| Smoking Cessation and Nicotine De-Addiction Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2024 | Forecast Period: | 2025-2032 |
| Historical Data: | 2019 to 2024 | Market Size in 2024: | USD 21.79 Bn. |
| Forecast Period 2025 to 2032 CAGR: | 18.9% | Market Size in 2032: | USD 87.03 Bn. |
| Segments Covered: | by Product Type | •Products (with Nicotine)
o OTC Products • Products (without Nicotine) o Prescription Products |
|
| by Distribution Channel | • Online • Offline |
||
Smoking Cessation and Nicotine De-Addiction Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Smoking Cessation and Nicotine De-Addiction Market Key Players:
1.Pfizer Inc.
2. GlaxoSmithKline plc (GSK)
3.Cipla Ltd.
4. Johnson & Johnson (J&J)
5. ITC Ltd.
6. Takeda Pharmaceutical Company Ltd.
7. Alkalon A/S
8. 22nd Century Group, Inc.
9. Strides Pharma Science Ltd.
10. JUUL Labs, Inc.
11. Imperial Brands
12. Japan Tobacco Inc.
13. British American Tobacco
14. Perrigo Company plc
15. Fertin Pharma
Frequently Asked Questions:
1. Which region has the largest share in Global Market?
Ans: North America region held the highest share in 2024.
2. What was the Global Smoking Cessation and Nicotine De-Addiction Market size in 2024?
Ans: The Global Smoking Cessation and Nicotine De-Addiction Market size was USD 21.79 Billion in 2024.
3. What is scope of the Global market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global market?
Ans: The important key players in the Global Market are – Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc., Strides Pharma Science Ltd., JUUL Labs, Inc., Imperial Brands, Japan Tobacco Inc., British American Tobacco, Perrigo Company plc, and Fertin Pharma.
5. What is the study period of this market?
Ans: The Global Market is studied from 2024 to 2032.
Table of Contents
Global Smoking Cessation and Nicotine De-Addiction Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Smoking Cessation and Nicotine De-Addiction Market, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
7.4. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Product Type
7.5. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Product Type
7.6. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Product Type
8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
8.4. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Distribution Channel
8.5. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Distribution Channel
8.6. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Distribution Channel
9. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Region
9.1. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Region
9.2. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Region
9.3. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Region
10. North America Smoking Cessation and Nicotine De-Addiction Market Analysis
10.1. Key Findings
10.2. North America Smoking Cessation and Nicotine De-Addiction Market Overview
10.3. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
10.4. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.4.1. Products (with Nicotine)
10.4.1.1. OTC Products
10.4.1.1.1. E-cigarettes
10.4.1.1.2. Nicotine Gums (NRT)
10.4.1.1.3. Nicotine Patches (NRT)
10.4.1.1.4. Nicotine Lozenges (NRT)
10.4.1.1.5. Nicotine Tablets (NRT)
10.4.1.2. Prescription Products
10.4.1.2.1. Nicotine Sprays (NRT)
10.4.1.2.2. Nicotine Inhalers (NRT)
10.4.2. Products (without Nicotine)
10.4.2.1. Prescription Products
10.4.2.1.1. Zyban
10.4.2.1.2. Chantix
10.5. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
10.6. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.6.1. Online
10.6.2. Offline
10.7. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
10.8. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
10.10. U.S. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.10.1. Products (with Nicotine)
10.10.1.1. OTC Products
10.10.1.1.1. E-cigarettes
10.10.1.1.2. Nicotine Gums (NRT)
10.10.1.1.3. Nicotine Patches (NRT)
10.10.1.1.4. Nicotine Lozenges (NRT)
10.10.1.1.5. Nicotine Tablets (NRT)
10.10.1.2. Prescription Products
10.10.1.2.1. Nicotine Sprays (NRT)
10.10.1.2.2. Nicotine Inhalers (NRT)
10.10.2. Products (without Nicotine)
10.10.2.1. Prescription Products
10.10.2.1.1. Zyban
10.10.2.1.2. Chantix
10.11. U.S. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.11.1. Online
10.11.2. Offline
10.12. Canada Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.12.1. Products (with Nicotine)
10.12.1.1. OTC Products
10.12.1.1.1. E-cigarettes
10.12.1.1.2. Nicotine Gums (NRT)
10.12.1.1.3. Nicotine Patches (NRT)
10.12.1.1.4. Nicotine Lozenges (NRT)
10.12.1.1.5. Nicotine Tablets (NRT)
10.12.1.2. Prescription Products
10.12.1.2.1. Nicotine Sprays (NRT)
10.12.1.2.2. Nicotine Inhalers (NRT)
10.12.2. Products (without Nicotine)
10.12.2.1. Prescription Products
10.12.2.1.1. Zyban
10.12.2.1.2. Chantix
10.13. Canada Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.13.1. Online
10.13.2. Offline
10.14. North America Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
10.14.1. By Product Type
10.14.2. By Distribution Channel
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development
11. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis
11.1. Key Findings
11.2. Europe Smoking Cessation and Nicotine De-Addiction Market Overview
11.3. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
11.4. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.4.1. Products (with Nicotine)
11.4.1.1. OTC Products
11.4.1.1.1. E-cigarettes
11.4.1.1.2. Nicotine Gums (NRT)
11.4.1.1.3. Nicotine Patches (NRT)
11.4.1.1.4. Nicotine Lozenges (NRT)
11.4.1.1.5. Nicotine Tablets (NRT)
11.4.1.2. Prescription Products
11.4.1.2.1. Nicotine Sprays (NRT)
11.4.1.2.2. Nicotine Inhalers (NRT)
11.4.2. Products (without Nicotine)
11.4.2.1. Prescription Products
11.4.2.1.1. Zyban
11.4.2.1.2. Chantix
11.5. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
11.6. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.6.1. Online
11.6.2. Offline
11.7. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
11.8. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
11.10. Germany Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.10.1. Products (with Nicotine)
11.10.1.1. OTC Products
11.10.1.1.1. E-cigarettes
11.10.1.1.2. Nicotine Gums (NRT)
11.10.1.1.3. Nicotine Patches (NRT)
11.10.1.1.4. Nicotine Lozenges (NRT)
11.10.1.1.5. Nicotine Tablets (NRT)
11.10.1.2. Prescription Products
11.10.1.2.1. Nicotine Sprays (NRT)
11.10.1.2.2. Nicotine Inhalers (NRT)
11.10.2. Products (without Nicotine)
11.10.2.1. Prescription Products
11.10.2.1.1. Zyban
11.10.2.1.2. Chantix
11.11. Germany Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.11.1. Online
11.11.2. Offline
11.12. U.K. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.12.1. Products (with Nicotine)
11.12.1.1. OTC Products
11.12.1.1.1. E-cigarettes
11.12.1.1.2. Nicotine Gums (NRT)
11.12.1.1.3. Nicotine Patches (NRT)
11.12.1.1.4. Nicotine Lozenges (NRT)
11.12.1.1.5. Nicotine Tablets (NRT)
11.12.1.2. Prescription Products
11.12.1.2.1. Nicotine Sprays (NRT)
11.12.1.2.2. Nicotine Inhalers (NRT)
11.12.2. Products (without Nicotine)
11.12.2.1. Prescription Products
11.12.2.1.1. Zyban
11.12.2.1.2. Chantix
11.13. U.K. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.13.1. Online
11.13.2. Offline
11.14. France Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.14.1. Products (with Nicotine)
11.14.1.1. OTC Products
11.14.1.1.1. E-cigarettes
11.14.1.1.2. Nicotine Gums (NRT)
11.14.1.1.3. Nicotine Patches (NRT)
11.14.1.1.4. Nicotine Lozenges (NRT)
11.14.1.1.5. Nicotine Tablets (NRT)
11.14.1.2. Prescription Products
11.14.1.2.1. Nicotine Sprays (NRT)
11.14.1.2.2. Nicotine Inhalers (NRT)
11.14.2. Products (without Nicotine)
11.14.2.1. Prescription Products
11.14.2.1.1. Zyban
11.14.2.1.2. Chantix
11.15. France Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.15.1. Online
11.15.2. Offline
11.16. Italy Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.16.1. Products (with Nicotine)
11.16.1.1. OTC Products
11.16.1.1.1. E-cigarettes
11.16.1.1.2. Nicotine Gums (NRT)
11.16.1.1.3. Nicotine Patches (NRT)
11.16.1.1.4. Nicotine Lozenges (NRT)
11.16.1.1.5. Nicotine Tablets (NRT)
11.16.1.2. Prescription Products
11.16.1.2.1. Nicotine Sprays (NRT)
11.16.1.2.2. Nicotine Inhalers (NRT)
11.16.2. Products (without Nicotine)
11.16.2.1. Prescription Products
11.16.2.1.1. Zyban
11.16.2.1.2. Chantix
11.17. Italy Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.17.1. Online
11.17.2. Offline
11.18. Spain Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.18.1. Products (with Nicotine)
11.18.1.1. OTC Products
11.18.1.1.1. E-cigarettes
11.18.1.1.2. Nicotine Gums (NRT)
11.18.1.1.3. Nicotine Patches (NRT)
11.18.1.1.4. Nicotine Lozenges (NRT)
11.18.1.1.5. Nicotine Tablets (NRT)
11.18.1.2. Prescription Products
11.18.1.2.1. Nicotine Sprays (NRT)
11.18.1.2.2. Nicotine Inhalers (NRT)
11.18.2. Products (without Nicotine)
11.18.2.1. Prescription Products
11.18.2.1.1. Zyban
11.18.2.1.2. Chantix
11.19. Spain Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.19.1. Online
11.19.2. Offline
11.20. Rest of Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.20.1. Products (with Nicotine)
11.20.1.1. OTC Products
11.20.1.1.1. E-cigarettes
11.20.1.1.2. Nicotine Gums (NRT)
11.20.1.1.3. Nicotine Patches (NRT)
11.20.1.1.4. Nicotine Lozenges (NRT)
11.20.1.1.5. Nicotine Tablets (NRT)
11.20.1.2. Prescription Products
11.20.1.2.1. Nicotine Sprays (NRT)
11.20.1.2.2. Nicotine Inhalers (NRT)
11.20.2. Products (without Nicotine)
11.20.2.1. Prescription Products
11.20.2.1.1. Zyban
11.20.2.1.2. Chantix
11.21. Rest of Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.21.1. Online
11.21.2. Offline
11.22. Europe Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
11.22.1. By Product Type
11.22.2. By Distribution Channel
11.23. PEST Analysis
11.24. Key Trends
11.25. Key Development
12. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis
12.1. Key Findings
12.2. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Overview
12.3. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
12.4. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.4.1. Products (with Nicotine)
12.4.1.1. OTC Products
12.4.1.1.1. E-cigarettes
12.4.1.1.2. Nicotine Gums (NRT)
12.4.1.1.3. Nicotine Patches (NRT)
12.4.1.1.4. Nicotine Lozenges (NRT)
12.4.1.1.5. Nicotine Tablets (NRT)
12.4.1.2. Prescription Products
12.4.1.2.1. Nicotine Sprays (NRT)
12.4.1.2.2. Nicotine Inhalers (NRT)
12.4.2. Products (without Nicotine)
12.4.2.1. Prescription Products
12.4.2.1.1. Zyban
12.4.2.1.2. Chantix
12.5. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
12.6. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.6.1. Online
12.6.2. Offline
12.7. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
12.8. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
12.10. China Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.10.1. Products (with Nicotine)
12.10.1.1. OTC Products
12.10.1.1.1. E-cigarettes
12.10.1.1.2. Nicotine Gums (NRT)
12.10.1.1.3. Nicotine Patches (NRT)
12.10.1.1.4. Nicotine Lozenges (NRT)
12.10.1.1.5. Nicotine Tablets (NRT)
12.10.1.2. Prescription Products
12.10.1.2.1. Nicotine Sprays (NRT)
12.10.1.2.2. Nicotine Inhalers (NRT)
12.10.2. Products (without Nicotine)
12.10.2.1. Prescription Products
12.10.2.1.1. Zyban
12.10.2.1.2. Chantix
12.11. China Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.11.1. Online
12.11.2. Offline
12.12. India Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.12.1. Products (with Nicotine)
12.12.1.1. OTC Products
12.12.1.1.1. E-cigarettes
12.12.1.1.2. Nicotine Gums (NRT)
12.12.1.1.3. Nicotine Patches (NRT)
12.12.1.1.4. Nicotine Lozenges (NRT)
12.12.1.1.5. Nicotine Tablets (NRT)
12.12.1.2. Prescription Products
12.12.1.2.1. Nicotine Sprays (NRT)
12.12.1.2.2. Nicotine Inhalers (NRT)
12.12.2. Products (without Nicotine)
12.12.2.1. Prescription Products
12.12.2.1.1. Zyban
12.12.2.1.2. Chantix
12.13. India Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.13.1. Online
12.13.2. Offline
12.14. Japan Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.14.1. Products (with Nicotine)
12.14.1.1. OTC Products
12.14.1.1.1. E-cigarettes
12.14.1.1.2. Nicotine Gums (NRT)
12.14.1.1.3. Nicotine Patches (NRT)
12.14.1.1.4. Nicotine Lozenges (NRT)
12.14.1.1.5. Nicotine Tablets (NRT)
12.14.1.2. Prescription Products
12.14.1.2.1. Nicotine Sprays (NRT)
12.14.1.2.2. Nicotine Inhalers (NRT)
12.14.2. Products (without Nicotine)
12.14.2.1. Prescription Products
12.14.2.1.1. Zyban
12.14.2.1.2. Chantix
12.15. Japan Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.15.1. Online
12.15.2. Offline
12.16. ASEAN Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.16.1. Products (with Nicotine)
12.16.1.1. OTC Products
12.16.1.1.1. E-cigarettes
12.16.1.1.2. Nicotine Gums (NRT)
12.16.1.1.3. Nicotine Patches (NRT)
12.16.1.1.4. Nicotine Lozenges (NRT)
12.16.1.1.5. Nicotine Tablets (NRT)
12.16.1.2. Prescription Products
12.16.1.2.1. Nicotine Sprays (NRT)
12.16.1.2.2. Nicotine Inhalers (NRT)
12.16.2. Products (without Nicotine)
12.16.2.1. Prescription Products
12.16.2.1.1. Zyban
12.16.2.1.2. Chantix
12.17. ASEAN Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.17.1. Online
12.17.2. Offline
12.18. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.18.1. Products (with Nicotine)
12.18.1.1. OTC Products
12.18.1.1.1. E-cigarettes
12.18.1.1.2. Nicotine Gums (NRT)
12.18.1.1.3. Nicotine Patches (NRT)
12.18.1.1.4. Nicotine Lozenges (NRT)
12.18.1.1.5. Nicotine Tablets (NRT)
12.18.1.2. Prescription Products
12.18.1.2.1. Nicotine Sprays (NRT)
12.18.1.2.2. Nicotine Inhalers (NRT)
12.18.2. Products (without Nicotine)
12.18.2.1. Prescription Products
12.18.2.1.1. Zyban
12.18.2.1.2. Chantix
12.19. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.19.1. Online
12.19.2. Offline
12.20. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
12.20.1. By Product Type
12.20.2. By Distribution Channel
12.21. PEST Analysis
12.22. Key Trends
12.23. Key Development
13. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Overview
13.3. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
13.4. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.4.1. Products (with Nicotine)
13.4.1.1. OTC Products
13.4.1.1.1. E-cigarettes
13.4.1.1.2. Nicotine Gums (NRT)
13.4.1.1.3. Nicotine Patches (NRT)
13.4.1.1.4. Nicotine Lozenges (NRT)
13.4.1.1.5. Nicotine Tablets (NRT)
13.4.1.2. Prescription Products
13.4.1.2.1. Nicotine Sprays (NRT)
13.4.1.2.2. Nicotine Inhalers (NRT)
13.4.2. Products (without Nicotine)
13.4.2.1. Prescription Products
13.4.2.1.1. Zyban
13.4.2.1.2. Chantix
13.5. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
13.6. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.6.1. Online
13.6.2. Offline
13.7. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
13.8. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
13.10. GCC Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.10.1. Products (with Nicotine)
13.10.1.1. OTC Products
13.10.1.1.1. E-cigarettes
13.10.1.1.2. Nicotine Gums (NRT)
13.10.1.1.3. Nicotine Patches (NRT)
13.10.1.1.4. Nicotine Lozenges (NRT)
13.10.1.1.5. Nicotine Tablets (NRT)
13.10.1.2. Prescription Products
13.10.1.2.1. Nicotine Sprays (NRT)
13.10.1.2.2. Nicotine Inhalers (NRT)
13.10.2. Products (without Nicotine)
13.10.2.1. Prescription Products
13.10.2.1.1. Zyban
13.10.2.1.2. Chantix
13.11. GCC Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.11.1. Online
13.11.2. Offline
13.12. South Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.12.1. Products (with Nicotine)
13.12.1.1. OTC Products
13.12.1.1.1. E-cigarettes
13.12.1.1.2. Nicotine Gums (NRT)
13.12.1.1.3. Nicotine Patches (NRT)
13.12.1.1.4. Nicotine Lozenges (NRT)
13.12.1.1.5. Nicotine Tablets (NRT)
13.12.1.2. Prescription Products
13.12.1.2.1. Nicotine Sprays (NRT)
13.12.1.2.2. Nicotine Inhalers (NRT)
13.12.2. Products (without Nicotine)
13.12.2.1. Prescription Products
13.12.2.1.1. Zyban
13.12.2.1.2. Chantix
13.13. South Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.13.1. Online
13.13.2. Offline
13.14. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.14.1. Products (with Nicotine)
13.14.1.1. OTC Products
13.14.1.1.1. E-cigarettes
13.14.1.1.2. Nicotine Gums (NRT)
13.14.1.1.3. Nicotine Patches (NRT)
13.14.1.1.4. Nicotine Lozenges (NRT)
13.14.1.1.5. Nicotine Tablets (NRT)
13.14.1.2. Prescription Products
13.14.1.2.1. Nicotine Sprays (NRT)
13.14.1.2.2. Nicotine Inhalers (NRT)
13.14.2. Products (without Nicotine)
13.14.2.1. Prescription Products
13.14.2.1.1. Zyban
13.14.2.1.2. Chantix
13.15. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.15.1. Online
13.15.2. Offline
13.16. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
13.16.1. By Product Type
13.16.2. By Distribution Channel
13.17. PEST Analysis
13.18. Key Trends
13.19. Key Development
14. South America Smoking Cessation and Nicotine De-Addiction Market Analysis
14.1. Key Findings
14.2. South America Smoking Cessation and Nicotine De-Addiction Market Overview
14.3. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
14.4. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.4.1. Products (with Nicotine)
14.4.1.1. OTC Products
14.4.1.1.1. E-cigarettes
14.4.1.1.2. Nicotine Gums (NRT)
14.4.1.1.3. Nicotine Patches (NRT)
14.4.1.1.4. Nicotine Lozenges (NRT)
14.4.1.1.5. Nicotine Tablets (NRT)
14.4.1.2. Prescription Products
14.4.1.2.1. Nicotine Sprays (NRT)
14.4.1.2.2. Nicotine Inhalers (NRT)
14.4.2. Products (without Nicotine)
14.4.2.1. Prescription Products
14.4.2.1.1. Zyban
14.4.2.1.2. Chantix
14.5. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
14.6. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.6.1. Online
14.6.2. Offline
14.7. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
14.8. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. South America Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
14.10. Brazil Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.10.1. Products (with Nicotine)
14.10.1.1. OTC Products
14.10.1.1.1. E-cigarettes
14.10.1.1.2. Nicotine Gums (NRT)
14.10.1.1.3. Nicotine Patches (NRT)
14.10.1.1.4. Nicotine Lozenges (NRT)
14.10.1.1.5. Nicotine Tablets (NRT)
14.10.1.2. Prescription Products
14.10.1.2.1. Nicotine Sprays (NRT)
14.10.1.2.2. Nicotine Inhalers (NRT)
14.10.2. Products (without Nicotine)
14.10.2.1. Prescription Products
14.10.2.1.1. Zyban
14.10.2.1.2. Chantix
14.11. Brazil Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.11.1. Online
14.11.2. Offline
14.12. Mexico Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.12.1. Products (with Nicotine)
14.12.1.1. OTC Products
14.12.1.1.1. E-cigarettes
14.12.1.1.2. Nicotine Gums (NRT)
14.12.1.1.3. Nicotine Patches (NRT)
14.12.1.1.4. Nicotine Lozenges (NRT)
14.12.1.1.5. Nicotine Tablets (NRT)
14.12.1.2. Prescription Products
14.12.1.2.1. Nicotine Sprays (NRT)
14.12.1.2.2. Nicotine Inhalers (NRT)
14.12.2. Products (without Nicotine)
14.12.2.1. Prescription Products
14.12.2.1.1. Zyban
14.12.2.1.2. Chantix
14.13. Mexico Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.13.1. Online
14.13.2. Offline
14.14. Rest of South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.14.1. Products (with Nicotine)
14.14.1.1. OTC Products
14.14.1.1.1. E-cigarettes
14.14.1.1.2. Nicotine Gums (NRT)
14.14.1.1.3. Nicotine Patches (NRT)
14.14.1.1.4. Nicotine Lozenges (NRT)
14.14.1.1.5. Nicotine Tablets (NRT)
14.14.1.2. Prescription Products
14.14.1.2.1. Nicotine Sprays (NRT)
14.14.1.2.2. Nicotine Inhalers (NRT)
14.14.2. Products (without Nicotine)
14.14.2.1. Prescription Products
14.14.2.1.1. Zyban
14.14.2.1.2. Chantix
14.15. Rest of South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.15.1. Online
14.15.2. Offline
14.16. South America Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
14.16.1. By Product Type
14.16.2. By Distribution Channel
14.17. PEST Analysis
14.18. Key Trends
14.19. Key Development
15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Pfizer Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Company Footprint
15.3.2. GlaxoSmithKline plc (GSK)
15.3.3. Cipla Ltd.
15.3.4. Johnson & Johnson (J&J)
15.3.5. ITC Ltd.
15.3.6. Takeda Pharmaceutical Company Ltd.
15.3.7. Alkalon A/S
15.3.8. 22nd Century Group, Inc.
15.3.9. Strides Pharma Science Ltd.
15.3.10. JUUL Labs, Inc.
15.3.11. Imperial Brands
15.3.12. Japan Tobacco Inc.
15.3.13. British American Tobacco
15.3.14. Perrigo Company plc
15.3.15. Fertin Pharma
16. Primary Key Insights